Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first time. Also known as tirzepatide, the drug will become available to around 220,

Prescriptions for the weight-loss jab Mounjaro are now being offered at GP surgeries in England - but only for patients who meet strict criteria. The move marks the beginning of a phases rollout of the weekly injection, which has been shown to help people lose up to 20% of their body weight.

But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as the health service begins its mass rollout. Some 220,000 people with the "greatest need" are expected to receive Mounjaro, made by pharmaceutical company Lilly, through the NHS over the next three years.